In our daily series of Q&As, we profile Bioeconomy Science Institute CEO Mark Piper.
Decision made before controversy over 'Eurasian fluff' remarks, says DGL boss.
Co-op still analysing its options after flagging possible IPO.
Dividends to shareholders are similarly up, bonuses to staff double.
TamoRx aims to develop world-leading cancer immunotherapy.
Mortgage interest rates and deposit rates likely to rise in response.
Submitters register alarm at IRD proposals for business owners.
After more than doubling sales last year the company has its sights set on Toyota's crown.
The company has officially launched domestic operations in Wellington.
Aotea Asset Management has committed close to $100m of loans in a year.
